Liu Zheng, Zhang Sicai, Chen Peng, Tian Songhai, Zeng Ji, Perry Kay, Dong Min, Jin Rongsheng
Department of Physiology and Biophysics, University of California, Irvine, Irvine, CA 92697, USA.
Department of Urology, Boston Children's Hospital, and Departments of Microbiology and Surgery, Harvard Medical School, Boston, MA 02115, USA.
Sci Adv. 2021 Oct 22;7(43):eabi4582. doi: 10.1126/sciadv.abi4582.
Toxin B (TcdB) is a primary cause of infection (CDI). This toxin acts by glucosylating small GTPases in the Rho/Ras families, but the structural basis for TcdB recognition and selectivity of specific GTPase substrates remain unsolved. Here, we report the cocrystal structures of the glucosyltransferase domain (GTD) of two distinct TcdB variants in complex with human Cdc42 and R-Ras, respectively. These structures reveal a common structural mechanism by which TcdB recognizes Rho and R-Ras. Furthermore, we find selective clustering of adaptive residue changes in GTDs that determine their substrate preferences, which helps partition all known TcdB variants into two groups that display distinct specificities toward Rho or R-Ras. Mutations that selectively disrupt GTPases binding reduce the glucosyltransferase activity of the GTD and the toxicity of TcdB holotoxin. These findings establish the structural basis for TcdB recognition of small GTPases and reveal strategies for therapeutic interventions for CDI.
毒素B(TcdB)是艰难梭菌感染(CDI)的主要病因。这种毒素通过对Rho/Ras家族中的小GTP酶进行糖基化发挥作用,但TcdB识别特定GTP酶底物的结构基础仍未解决。在此,我们报告了两种不同TcdB变体的糖基转移酶结构域(GTD)分别与人Cdc42和R-Ras形成复合物的共晶体结构。这些结构揭示了TcdB识别Rho和R-Ras的共同结构机制。此外,我们发现GTD中适应性残基变化的选择性聚类决定了它们的底物偏好,这有助于将所有已知的TcdB变体分为两组,它们对Rho或R-Ras表现出不同的特异性。选择性破坏GTP酶结合的突变会降低GTD的糖基转移酶活性和TcdB全毒素的毒性。这些发现确立了TcdB识别小GTP酶的结构基础,并揭示了针对CDI的治疗干预策略。